Board meeting outcome for approval of un-audited Financial Results for the Quarter and Nine Months ended 31st December, 2025.
Awaiting price reaction for this filing.
Soni Medicare Ltd's Board approved unaudited results for Q3 FY26 and 9M ended Dec 31, 2025. Revenue from operations fell sharply to Rs 536.49 lakhs in Q3 FY26, down ~14% sequentially and ~29% year-on-year from Rs 752.36 lakhs in Q3 FY25. For the 9-month period, revenue dropped ~18% YoY to Rs 1,887.67 lakhs versus Rs 2,297.00 lakhs a year ago. Total expenses of Rs 2,199.76 lakhs now exceed total income of Rs 1,966.34 lakhs for 9M FY26. Net loss widened to Rs 234.17 lakhs (9M FY26) from Rs 53.34 lakhs a year ago, with Q3 alone posting a loss of Rs 113.12 lakhs versus Rs 13.31 lakhs in Q3 FY25. The auditor (Tambi Ashok & Associates) issued an unqualified limited review report. The Board also appointed Mr. Lavi Kumar Mutha as Non-Executive Independent Director for 5 years.
Worsening operational performance is a significant concern — revenue is shrinking while losses are deepening, with expenses now outpacing income. Shareholders may view this negatively given the clear deterioration; however, the clean auditor review and continuity of operations offer some reassurance.